| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |